Optical Genome Mapping Market Synopsis

Optical Genome Mapping Market Size Was Valued at USD 102.00 Million in 2023, and is Projected to Reach USD 867.39 Million by 2032, Growing at a CAGR of 26.85% From 2024-2032.

• The Optical Genome Mapping (OGM) market relates to instruments and technologies used for accurate and less time-consuming large scale structural variation identification and genome analysis using light based imaging. OGM is also applied in a number of fields for instance genetics, diagnosis of diseases, as well as in precision medicine for establishment of genetic complexity and mutation. The growth is attributed by these factors such as new technologies in biotechnology, higher demands for tailor-made treatments, and demand for broader and deeper information on genome in the healthcare and research industries.
• The market for Optical Genome Mapping (OGM) is growing rapidly, eventually developed from generating the better and further protein sequencing with the help of genomic science. OGM technology provides an innovative approach to identify significant over 650bp structural variations in DNA, including insertions, deletions, and translocations, which are not dectected by other sequencing technique. OGM has importance in specifying the mutations that are likely to causative for many diseases like canker and other strains of genetic disorders which is important for high precision medicine. Thus, the increased focus on individualized therapy together with the high value of the OGM database as well as lower cost and shorter time required for data acquisition in comparison with other techniques is stimulating further OGM application in clinical and research practice.
• Furthermore, the OGM market is experiencing continued growth of partnerships between university and research facility, biotechnology firms and healthcare facilities to advance the use of OGMs for different applications. OGM System is quickly evolving since competitors are increasing R & D to enhance its appropriateness and generally, the market growth is due to the constant enhancement of the accuracy and usability of such systems. Also, increasing knowledge of the usage of genomic research in diagnostics, as well as a favourable government position with weighing and support, the market has the prospect for further development. Nevertheless, some factors like shortage of professional staff, high costs of application of innovative genomic solutions can to some extent restrain market development. Nevertheless, the global OGM market faces several challenges which, however, are counterbalanced by the trend towards further development of OGM market as people’s requirements to comprehensive genomic analysis grow.

Optical Genome Mapping Market Trend Analysis

Rising Prevalence of Genetic Disorders and the Growing Role of Optical Genome Mapping in Precision Medicine

• Another important trend of the optical genome mapping is the expansion of the genetic disorders and cancers rates which has led to the higher incorporation of the optical genome mapping for the diagnostic and treatment job planning. It becomes evident that with increasing demand for more precise analysis of genes requiring serious attention to LSVs, the optical genome mapping remains the only tool for a high-resolution outlook into the region. These structural changes, including duplications, deletions, and translocations are frequently cryptic by typical depressive sequencing techniques . Optical genome mapping has thus proved to be crucial for identifying these variations of importance for understanding a myriad of diseases ranging from cancers, rare genetic disorders, and hereditary diseases, by helping researchers and clinicians to get sufficient detail of these variations.
• Furthermore, as the specialist in precision medicine is growing, optical genome mapping will also be the focus of the field and development of individual therapies. It makes therapy more personalised because a person’s genotype can be worked out more accurately and treatment with consistent strategies, which conform to this genotype, can therefore commence. For instance, in oncology, by using optical genome mapping clinicians get an idea about the specific changes in the patients’ DNA that led to the development of cancer; thus, they can choose which therapy type would be most effective for the patient. This shift towards personalised medicine is further improving the importance of OGM in clinical application which is boosting the demand for it all across healthcare in the world.

Integration with Genomic Technologies and Advancements in Optical Genome Mapping Platforms

• Another important tendency that can be described in terms of the market of optical genome maps is the linkage with other innovative methods in the field of genomics such as NGS and CRISPR/Cas9-mediated genome editing. This combination improves the understanding of genetic differences because it encompass broader information about structural variations while NGS provides additional data on the subject. Therefore , bringing together these technologies will enable the researchers to improve the accuracy of identifying multiple genetic variations and the role of each gene in disorder pathogenesis, especially with reference to rare genetic and neurological disorders. This broader understanding makes for better diagnostics, treatment, new therapy approaches, research findings, and, therefore, better results for patients in clinical practice.
• Besides, the growth of optical genome mapping is propelled by technological progresses in the mapping platforms that are increasingly becoming effective, accurate and cheaper. Technological developments in areas including higher resolution, increased computation speed, and enhanced software for the analysis of data, are seeing the platforms become ever more appealing in a variety of applications from academic research institutions to pharmaceutical firms and clinical laboratories. These are welcome development because they are not only making optical genome mapping cheaper but are also extending its use to diagnosis of diseases and new drug discovery. Hence, the development of this new technology termed as the optical genome mapping is expanding the market segments in virtually every context from industry to medicine and thus propelling the overall growth path of the market.

Optical Genome Mapping Market Segment Analysis:

Optical Genome Mapping Segmented based on By Product and By Technique

By Product, Instruments segment is expected to dominate the market during the forecast period

• Equipments are basic facilities in biotechnology science, offering the necessary infrastructure for numerous diverse experiment and analysis operations. This segment comprises sequencing machines, PCR system, and other mass spectrometers that are categorized under high throughput products. These instruments enable the researchers to perform a variety of genetically and molecular analyses more effectively and accurately. These tool have become highly advanced through the influence of technology to deliver automated systems with increased precision, output and little or no human interference. These innovations enable elongated and complex analyses to be achieved in a greater capacity and thereby enhance breakthroughs in numerous research fields.
• The need for more advanced models is mainly explained by the current research in genomica, proteomica and personalized medical approach, where speed and accuracy of measurements is crucial. Given the dynamic growth of the field, the incorporation of sophisticated technologies into laboratory procedures assumes even greater significance. As studies are increasing the requirements of instruments are expanded not only for increasing efficiency but for their favorable reliability in the increasing complex research. This trend implies that the improved devices need to be developed in order to meet the further scientific and technical progress which leads to better diagnostic tools, more efficient and individualized therapies, as well as better understanding of the biological processes.

By Technique, Structural Variant Detection segment held the largest share in 2023

• Structural variant analysis is an essential assay in genetics that involves the identification of changes in chromosomes such as copy number variations, deletions, duplicate, insertions, inversions, translocations and transpositions. These structural differences may significantly influence gene activity and, therefore, cause numerous genetic diseases that contribute to phenotypic differentiation of persons. Knowledge of these alterations is critical in making sense for genetic diseases and the strategies that underlie them. Structural variants have emerged as encompassing substantial variations in the genome of an individual and are now routinely identified using high-resolution techniques like next-generation sequencing (NGS) and array comparative genomic hybridization (aCGH).
• Among these, there is a striking rise in the genetic disorders requiring accurate structural variant detection methodology and globalization and the trend towards precision medicine. Genetic diagnostic tools are thus progressively more important to diagnose and treat diseases as researcher and clinician try to identify disease genes. Currently structural variant detection has been valuable in propelling knowledge on how structural variants cause health and disease hence pushing advancements on personalised medicine where an individual is treated on the basis of his/her genetics. This continuous interest in structural variants has been underpinned their relevance in clinical and research practice which ultimately enhances health.

Optical Genome Mapping Market Regional Insights:

Asia-Pacific is Expected to Dominate the Market Over the Forecast period

• Currently, the Asia-Pacific region has become the largest growth territory for the optical genome mapping market due to the steady growth of healthcare expenditures, the expansion of research projects, and the increased popularity of genomic technologies. China and Japan are in the front row of this expansion, a huge investment is being made with reference to Genomics- Research and Development. In China, driving factors for development of precision medicine are in the government framework which focuses on improving disease diagnosis and treatment. However, the level of ailment as well as the need for accurate diagnosis and individualized plans to treat diseases is increasing due to the constant aging population in Japan which in turn will boost the demand for optical genome mapping technologies.
• Other than the two giants China and Japan several countries like India, Korea, Singapore, Australia are also gaining prominence in the optical genome mapping market. These nations are experiencing healthcare development which enhances acceptance of new genomic technologies in to practice. India is devoting more attention to gene research that is leading to new inventions, South Korea has developed itself in biotechnology and genomics due to cooperation between the government and private sectors. Australia is also strengthening its genomic capacity to manage complex niches in the health sector. Collectively these factors are driving the growth for optical genome mapping and creating a constantly shifting and highly competitive market across the Asia Pacific region.

Active Key Players in the Optical Genome Mapping Market

• Bionano Genomics
• Nucleome Informatics Private Limited
• Praxis Genomics, LLC,
• SourceBio International Limited (Source BioScience)
• MedGenome
• INRAE (French Plant Genomic Resources Center (CNRGV))
• PerkinElmer (PerkinElmer Genomics)
• Genohub Inc.
• Hofkens Lab
• Cerba
• Other Key Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Optical Genome Mapping Market by Product
 4.1 Optical Genome Mapping Market Snapshot and Growth Engine
 4.2 Optical Genome Mapping Market Overview
 4.3 Instruments
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Instruments: Geographic Segmentation Analysis
 4.4 Consumables & Reagents
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Consumables & Reagents: Geographic Segmentation Analysis
 4.5 Software
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Software: Geographic Segmentation Analysis
 4.6 Services
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Services: Geographic Segmentation Analysis

Chapter 5: Optical Genome Mapping Market by Technique
 5.1 Optical Genome Mapping Market Snapshot and Growth Engine
 5.2 Optical Genome Mapping Market Overview
 5.3 Structural Variant Detection
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Structural Variant Detection: Geographic Segmentation Analysis
 5.4 Genome Assembly
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Genome Assembly: Geographic Segmentation Analysis
 5.5 Microbial Strain Typing
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Microbial Strain Typing: Geographic Segmentation Analysis
 5.6 Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Others: Geographic Segmentation Analysis

Chapter 6: Optical Genome Mapping Market by End-User
 6.1 Optical Genome Mapping Market Snapshot and Growth Engine
 6.2 Optical Genome Mapping Market Overview
 6.3 Biotechnology & Pharmaceutical Companies
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Biotechnology & Pharmaceutical Companies: Geographic Segmentation Analysis
 6.4 Hospitals & Clinical Laboratories
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Hospitals & Clinical Laboratories: Geographic Segmentation Analysis
 6.5 Hospitals & Clinical Laboratories
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Hospitals & Clinical Laboratories: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Optical Genome Mapping Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 BIONANO GENOMICS
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 NUCLEOME INFORMATICS PRIVATE LIMITED
 7.4 PRAXIS GENOMICS LLC
 7.5 SOURCEBIO INTERNATIONAL LIMITED (SOURCE BIOSCIENCE)
 7.6 MEDGENOME
 7.7 INRAE (FRENCH PLANT GENOMIC RESOURCES CENTER (CNRGV))
 7.8 PERKINELMER (PERKINELMER GENOMICS)
 7.9 GENOHUB INC
 7.10 HOFKENS LAB
 7.11 CERBA
 7.12 OTHER ACTIVE PLAYERS

Chapter 8: Global Optical Genome Mapping Market By Region
 8.1 Overview
 8.2. North America Optical Genome Mapping Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Product
  8.2.4.1 Instruments
  8.2.4.2 Consumables & Reagents
  8.2.4.3 Software
  8.2.4.4 Services
  8.2.5 Historic and Forecasted Market Size By Technique
  8.2.5.1 Structural Variant Detection
  8.2.5.2 Genome Assembly
  8.2.5.3 Microbial Strain Typing
  8.2.5.4 Others
  8.2.6 Historic and Forecasted Market Size By End-User
  8.2.6.1 Biotechnology & Pharmaceutical Companies
  8.2.6.2 Hospitals & Clinical Laboratories
  8.2.6.3 Hospitals & Clinical Laboratories
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Optical Genome Mapping Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Product
  8.3.4.1 Instruments
  8.3.4.2 Consumables & Reagents
  8.3.4.3 Software
  8.3.4.4 Services
  8.3.5 Historic and Forecasted Market Size By Technique
  8.3.5.1 Structural Variant Detection
  8.3.5.2 Genome Assembly
  8.3.5.3 Microbial Strain Typing
  8.3.5.4 Others
  8.3.6 Historic and Forecasted Market Size By End-User
  8.3.6.1 Biotechnology & Pharmaceutical Companies
  8.3.6.2 Hospitals & Clinical Laboratories
  8.3.6.3 Hospitals & Clinical Laboratories
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Optical Genome Mapping Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Product
  8.4.4.1 Instruments
  8.4.4.2 Consumables & Reagents
  8.4.4.3 Software
  8.4.4.4 Services
  8.4.5 Historic and Forecasted Market Size By Technique
  8.4.5.1 Structural Variant Detection
  8.4.5.2 Genome Assembly
  8.4.5.3 Microbial Strain Typing
  8.4.5.4 Others
  8.4.6 Historic and Forecasted Market Size By End-User
  8.4.6.1 Biotechnology & Pharmaceutical Companies
  8.4.6.2 Hospitals & Clinical Laboratories
  8.4.6.3 Hospitals & Clinical Laboratories
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Optical Genome Mapping Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Product
  8.5.4.1 Instruments
  8.5.4.2 Consumables & Reagents
  8.5.4.3 Software
  8.5.4.4 Services
  8.5.5 Historic and Forecasted Market Size By Technique
  8.5.5.1 Structural Variant Detection
  8.5.5.2 Genome Assembly
  8.5.5.3 Microbial Strain Typing
  8.5.5.4 Others
  8.5.6 Historic and Forecasted Market Size By End-User
  8.5.6.1 Biotechnology & Pharmaceutical Companies
  8.5.6.2 Hospitals & Clinical Laboratories
  8.5.6.3 Hospitals & Clinical Laboratories
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Optical Genome Mapping Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Product
  8.6.4.1 Instruments
  8.6.4.2 Consumables & Reagents
  8.6.4.3 Software
  8.6.4.4 Services
  8.6.5 Historic and Forecasted Market Size By Technique
  8.6.5.1 Structural Variant Detection
  8.6.5.2 Genome Assembly
  8.6.5.3 Microbial Strain Typing
  8.6.5.4 Others
  8.6.6 Historic and Forecasted Market Size By End-User
  8.6.6.1 Biotechnology & Pharmaceutical Companies
  8.6.6.2 Hospitals & Clinical Laboratories
  8.6.6.3 Hospitals & Clinical Laboratories
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Optical Genome Mapping Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Product
  8.7.4.1 Instruments
  8.7.4.2 Consumables & Reagents
  8.7.4.3 Software
  8.7.4.4 Services
  8.7.5 Historic and Forecasted Market Size By Technique
  8.7.5.1 Structural Variant Detection
  8.7.5.2 Genome Assembly
  8.7.5.3 Microbial Strain Typing
  8.7.5.4 Others
  8.7.6 Historic and Forecasted Market Size By End-User
  8.7.6.1 Biotechnology & Pharmaceutical Companies
  8.7.6.2 Hospitals & Clinical Laboratories
  8.7.6.3 Hospitals & Clinical Laboratories
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research